<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03260309</url>
  </required_header>
  <id_info>
    <org_study_id>VilniusU</org_study_id>
    <nct_id>NCT03260309</nct_id>
  </id_info>
  <brief_title>The Influence of Perioperative Optimisation to the Hip Arthroplasty Outcomes</brief_title>
  <official_title>The Influence of Perioperative Optimisation to the Primary Hip Arthroplasty Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vilnius University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaunas University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vilnius University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Success of the hip arthroplasty depends on the measures that optimize perioperative
      conditions.It is planned to evaluate semi-closed loop system in the hip arthroplasty surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Success of the total hip arthroplasty depends on the measures that optimize perioperative
      conditions. They increase the emotional stress of the staff and error probability. It is
      planned to evaluate semi-closed loop infusion system, its adaption for infusion application's
      influence to near and far treatment outcomes done by prospective randomized clinical trial.
      This is done by performing total hip arthroplasty. It's expected to evaluate the semi-closed
      loop system's influence on the doctor's emotional tension during the decision making.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The efficiency of semi-closed loop infusion system</measure>
    <time_frame>Before the surgery and 12 hrs postoperatively</time_frame>
    <description>Determine the ratio of doctor's approved and rejected computer suggestions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative blood loss</measure>
    <time_frame>Before (baseline) the surgery,during surgery and 24hrs postoperatively</time_frame>
    <description>Non-invasive measurement of Hb (Masimo technology). Laboratory hemoglobin determination, evaluation of the bleeding volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coagulation activity</measure>
    <time_frame>Before (baseline) the surgery and 24hrs postoperatively</time_frame>
    <description>Coagulation activity is investigated thromboelastically</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infused fluid and red blood cell volume</measure>
    <time_frame>Before the surgery and 24hrs postoperatively</time_frame>
    <description>Repeated rehydration bolus (sol.Ringeri 2,5ml/kg), supportive fluid infusion (sol.NaCl 0,9% 1,5 ml/kg/hrs); evaluation of signs of anemia intolerance if Hb &lt; 110 g/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound healing</measure>
    <time_frame>Within 6 days postoperatively</time_frame>
    <description>Evaluation of wound tissue condition, measurement of drainage fluid volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage physical exercise sample</measure>
    <time_frame>Within 6 days postoperatively</time_frame>
    <description>Timed up and go test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamic stability</measure>
    <time_frame>Before (baseline) the surgery and 12 hrs postoperatively</time_frame>
    <description>Invasive measurement of arterial blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Within 6 days postoperatively</time_frame>
    <description>Registration of all complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>semi-closed system group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Semi-closed loop infusion system tactic. Programmed iv fluid and blood infusion system ,,Belmont Rapid Infuser&quot; and programmable syringe pump for adrenaline infusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine infusion therapy tactic</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Semi-closed loop infusion system tactic.</intervention_name>
    <description>Semi -closed loop infusion system tactic.Use volume loading test twice (before surgery and 12hrs postoperatively). Computer provides advisory hypotension treatment algorithm. Computer provides advisory anemia treatment algorithm. Programmed iv fluid and blood infusions system ,,Belmont Rapid Infuser&quot; and programmable syringe pump for adrenaline infusion.</description>
    <arm_group_label>semi-closed system group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Routine infusion therapy tactic</intervention_name>
    <description>Routine re-hydration bolus before surgery. Routine treatment of hypotension. Routine treatment of anemia.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with osteoarthritis of the hip undergoing hip arthroplasty with spinal -
             epidural anesthesia

          -  Age &gt;50 and &lt;85 years

          -  ASA (American Society of Anesthesiology Classification) II physical status

          -  Start of operation no later than 09:00

          -  Signed informed consent form

        Exclusion Criteria:

          -  Age &lt;50 and &gt;85 yers

          -  BMI (Body Mass Index) &lt;20 and &gt;40 kg/m2

          -  ASA I and ASA&gt;II physical status

          -  History of a bleeding disorder

          -  Anemia before surgery Hb&lt;110 g/l

          -  Intravascular fluid infusion within 24 hours before study

          -  Diabetes mellitus

          -  Previous open hip surgery

          -  Psychiatric illness (intake of other psychiatric medication than selective serotonin
             reuptake inhibitors)

          -  Alcohol intake 5 U daily

          -  Contraindication to spinal - epidural anesthesia

          -  Surgery not by project surgeon

          -  Start of operation later than 09:00

          -  Atrial fibrillation

          -  Narcotic addiction

          -  History of DVT (Deep Vein Thrombosis), thromboembolic complications, acute cardiac
             insufficiency

          -  Participation in the other study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrijauskas Audrius, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vilnius University</affiliation>
  </overall_official>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2017</study_first_posted>
  <last_update_submitted>August 25, 2017</last_update_submitted>
  <last_update_submitted_qc>August 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vilnius University</investigator_affiliation>
    <investigator_full_name>Darius Cincikas</investigator_full_name>
    <investigator_title>Audrius Andrijauskas PhD , principal investigator, clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

